Dr. Nicholas Zupec is a pharmacist who is specialized in Pharmacotherapy in Milwaukee, Wisconsin. Patients can reach him at 2900 W Oklahoma Ave, 7th Floor - Inpatient Pharmacy, Milwaukee or contact him on 414-649-5489. Active license number of Dr. Nicholas Zupec is 16857-40 for Pharmacotherapy in Wisconsin. Dr. Nicholas Zupec is a licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing pharmacotherapeutic care of patients, by developing, implementing, monitoring, and modifying complex treatment plans, providing advanced level education and consultation, and collaborating with other health professionals in the management of therapy.
Complete Profile:
Dr. Nicholas Zupec speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Dr. Nicholas Zupec are as mentioned below.
NPI Number:
1104251982
NPI Enumeration Date:
11 Sep, 2013
NPI Last Update On:
29 Mar, 2021
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Nicholas Zupec are as mentioned below.
Specialization
License Number
State
Status
Pharmacotherapy
16857-40
Wisconsin
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
3256 Estates Ct S, Saint Joseph, Michigan
Zip:
49085-3440
Phone Number:
847-347-7928
Fax Number:
--
Patients can reach Dr. Nicholas Zupec at 2900 W Oklahoma Ave, 7th Floor - Inpatient Pharmacy, Milwaukee, Wisconsin or can call on phone at 414-649-5489.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.